(State or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification Number) |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class | Trading symbol | Name of each exchange on which registered | ||
$0.001 par value per share
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
(d)
|
Exhibits.
|
Exhibit No.
|
Description
|
10.1
|
|
104
|
Cover Page Interactive Data File (formatted in inline XBRL)
|
ASENSUS SURGICAL, INC.
|
||
Date: April 30, 2021
|
/s/ Shameze Rampertab
|
|
Shameze Rampertab
|
||
EVP and Chief Financial Officer
|
Exhibit 10.1
Non-Employee Director Compensation Program
Effective July 1, 2021, the Asensus Surgical, Inc. Non-Employee Director Compensation Program is:
Annual Cash Retainer (1) |
Annual Equity Award (2) |
Initial Equity Award (2) |
||
Non-Employee Director role: |
Dollar value |
Election to be paid in equity |
Equity grant of stock options or restricted stock units with a value of $45,000. Director can elect the form of equity. Cliff vesting at first anniversary of grant or following year’s annual meeting date, if earlier, subject to forfeiture if not vested. |
Equity grant of stock options or restricted stock units with a value of $150,000. Incoming director can elect the form of equity. Vests one-third of award on each of the first three anniversaries of the date of grant. |
Baseline Board Retainer |
$50,000 |
Yearly election will be made by each director to receive cash retainer in shares of common stock or stock options |
||
Non-Executive Chair Additional Retainer |
$50,000 |
|||
Audit Committee Chair |
$20,000 |
|||
Compensation Committee Chair |
$13,000 |
|||
CG & Nominating Committee Chair |
$10,000 |
|||
Audit Committee Member |
$ 9,000 |
|||
Compensation Committee Member |
$ 6,000 |
|||
CG& Nominating Committee Member |
$ 5,000 |
(1) |
Annual non-employee director compensation limit of $250,000 with initial year compensation limit of $500,000 as set forth in the Amended and Restated Equity Compensation Plan (the “Plan”). |
(2) |
Number of shares of common stock, restricted stock units or stock options calculated using a stock price equal to the greater $1.00 or the average closing price in the 20 trading days prior to the date of grant and, for stock options, if elected by a director, a Black Scholes calculation. Stock options will have a seven-year term. |
Document And Entity Information |
Apr. 28, 2021 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | Asensus Surgical, Inc. |
Document, Type | 8-K |
Document, Period End Date | Apr. 28, 2021 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 0-19437 |
Entity, Tax Identification Number | 11-2962080 |
Entity, Address, Address Line One | 1 TW Alexander Drive |
Entity, Address, Address Line Two | Suite 160 |
Entity, Address, City or Town | Durham |
Entity, Address, State or Province | NC |
Entity, Address, Postal Zip Code | 27703 |
City Area Code | 919 |
Local Phone Number | 765-8400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ASXC |
Security Exchange Name | NYSEAMER |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000876378 |
-8?20$3;8T.P6BP^0"X99K>]9!:G